Department of Molecular Endocrinology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Department of Maternal Fetal Biology, National Research Institute for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
Clin Epigenetics. 2021 May 26;13(1):119. doi: 10.1186/s13148-021-01106-5.
ZNF445, as well as ZFP57, is involved in the postfertilization methylation maintenance of multiple imprinting-associated differentially methylated regions (iDMRs). Thus, ZNF445 pathogenic variants are predicted to cause multilocus imprinting disturbances (MLIDs), as do ZFP57 pathogenic variants. In particular, the MEG3/DLK1:IG-DMR would be affected, because the postzygotic methylation imprint of the MEG3/DLK1:IG-DMR is maintained primarily by ZNF445, whereas that of most iDMRs is preserved by both ZFP57 and ZNF445 or primarily by ZFP57.
We searched for a ZNF445 variant(s) in six patients with various imprinting disorders (IDs) caused by epimutations and MLIDs revealed by pyrosequencing for nine iDMRs, without a selection for the original IDs. Re-analysis of the previously obtained whole exome sequencing data identified a homozygous ZNF445 variant (NM_181489.6:c.2803C>T:p.(Gln935*)) producing a truncated protein missing two of 14 zinc finger domains in a patient with Temple syndrome and MLID. In this patient, array-based genomewide methylation analysis revealed severe hypomethylation of most CpGs at the MEG3:TSS-DMR, moderate hypomethylation of roughly two-thirds of CpGs at the H19/IGF2:IG-DMR, and mild-to-moderate hypomethylation of a few CpGs at the DIRAS3:TSS-DMR, MEST:alt-TSS-DMR, IGF2:Ex9-DMR, IGF2:alt-TSS, and GNAS-AS1:TSS-DMR. Furthermore, bisulfite sequencing analysis for the MEG3/DLK1:IG-DMR delineated a markedly hypomethylated segment (CG-A). The heterozygous parents were clinically normal and had virtually no aberrant methylation pattern.
We identified a ZNF445 pathogenic variant for the first time. Since ZNF445 binds to the MEG3/DLK1:IG-DMR and other iDMRs affected in this patient, the development of Temple syndrome and MLID would primarily be explained by the ZNF445 variant. Furthermore, CG-A may be the target site for ZNF445 within the MEG3/DLK1:IG-DMR.
ZNF445 与 ZFP57 一样,参与了多个印迹相关差异甲基化区域(iDMR)的受精后甲基化维持。因此,ZNF445 致病变异预计会导致多基因印迹障碍(MLIDs),ZFP57 致病变异也是如此。特别是 MEG3/DLK1:IG-DMR 会受到影响,因为 MEG3/DLK1:IG-DMR 的合子后甲基化印迹主要由 ZNF445 维持,而大多数 iDMR 的印迹则由 ZFP57 和 ZNF445 共同维持,或主要由 ZFP57 维持。
我们在六名患有由表观突变引起的各种印迹障碍(IDs)和通过焦磷酸测序显示的 MLIDs 的患者中搜索 ZNF445 变异(s),没有为原始 IDs 进行选择。对先前获得的全外显子组测序数据的重新分析发现,一名患有 Temple 综合征和 MLID 的患者存在纯合 ZNF445 变异(NM_181489.6:c.2803C>T:p.(Gln935*)),导致缺失 14 个锌指结构域中的两个的截断蛋白。在这名患者中,基于阵列的全基因组甲基化分析显示 MEG3:TSS-DMR 上的大多数 CpG 严重低甲基化,H19/IGF2:IG-DMR 上约三分之二的 CpG 中度低甲基化,DIRAS3:TSS-DMR、MEST:alt-TSS-DMR、IGF2:Ex9-DMR、IGF2:alt-TSS 和 GNAS-AS1:TSS-DMR 上少数 CpG 轻度至中度低甲基化。此外,对 MEG3/DLK1:IG-DMR 的亚硫酸氢盐测序分析描绘了一个明显低甲基化的片段(CG-A)。杂合父母临床表现正常,几乎没有异常的甲基化模式。
我们首次发现了 ZNF445 的致病变异。由于 ZNF445 与该患者受影响的 MEG3/DLK1:IG-DMR 和其他 iDMR 结合,Temple 综合征和 MLID 的发展主要可以用 ZNF445 变异来解释。此外,CG-A 可能是 ZNF445 在 MEG3/DLK1:IG-DMR 中的靶位。